- Home
- Plastic Surgery
- Aesthetic Surgery
- augmentation mammoplasty
- Breast implant removals
- Mastopexy
- Buttock lift
- Jaw reshaping
- Dermabrasion
- Blepharoplasty
- Rhytidectomy
- Forehead lift
- Hair Transplantation
- Lip augmentation
- Lipoplasty
- Lower body lift
- Rhinoplasty
- Thigh lift
- Abdominoplasty
- Brachioplasty
- Botox injections
- Cellulite treatment
- Chemical peel
- Facial rejuvenation
- Laser skin resurfacing
- Laser treatment of leg veins
- Vaginal rejuvenation
- Aesthetic Surgery
- Dentistry (Odontology)
- Miami fashion
- Real estate
- Entertainment
- lifestyle
Subscribe to Updates
Browsing: secures
Osheru Secures $4.7M in Funding to Advance Revolutionary Blepharoplasty Surgery Device Ziplyft
Funding to accelerate development and commercialization of company’s breakthrough blepharoplasty surgery device John Garland has been appointed as Chief Commercial Officer BEND, Ore., July 23, 2024–(BUSINESS…
SEATTLE, October 31, 2024 (Newswire.com) – Allure Esthetic and renowned plastic surgeon Dr. Javad Sajan are excited to announce a major breakthrough in transgender healthcare. In…
Osheru Secures $4.7M in Funding to Advance Revolutionary Blepharoplasty Surgery Device Ziplyft
Funding to accelerate development and commercialization of company’s breakthrough blepharoplasty surgery deviceJohn Garland has been appointed as Chief Commercial OfficerBEND, Ore., July 23, 2024–(BUSINESS WIRE)–Oseru, a…
Oseru has completed a $4.7 million funding round to accelerate the development and commercialization of its Ziplyft blepharoplasty surgery device.Individuals and family offices provided financial support,…
Pictured: Vertex Pharmaceuticals office in Boston, Massachusetts/iStock, hahahaha Vertex Pharmaceuticals announced Tuesday that the non-opioid pain treatment VX-548 completed three Phase III studiescausing significant pain reduction…
The GreenSky-backed University of Toronto spinout has set its initial sights on dentistry. Toronto-based nanotechnology startup Mesosil has closed $2.2 million CAD in seed funding to…
Pictured: Vertex Pharmaceuticals office in Boston, Massachusetts/iStock, hapapapa Vertex Pharmaceuticals announced Tuesday that its non-opioid pain treatment VX-548 completed three Phase III studiescausing significant pain reduction…